ESR1 and breast carcinoma: In breast cancer cells, acute activation of 17β-estradiol (E2) responsive enhancers requires the recruitment of a large protein complex, known as MegaTrans complex, in an estrogen receptor α (ERα) and enhancer RNA-dependent manner[98].